UW-Madison To Resume Enrolling Patients For Vaccine Trial

Sunday, November 1st, 2020 -- 8:13 AM

The University of Wisconsin-Madison will resume enrolling patients for a coronavirus vaccine trial next week.

The Associated Press reports that thirty-six people had received the first of two shots before the study at the School of Medicine and Public Health was paused in September. The study is for a coronavirus vaccine produced by Oxford University and the British pharmaceutical manufacturer AstraZeneca, which announced last Friday that testing would resume after it got clearance from the Food and Drug Administration.

Wisconsin Public Radio reported that the participants in the UW-Madison study will now have the option to receive their second dose of the vaccine and the school will resume enrolling volunteers.

Feel free to contact us with questions and/or comments.